论文部分内容阅读
目的对氨溴特罗辅治小儿喘息性疾病的临床疗效进行观察。方法选取2011年12月—2012年12月符合诊断标准的住院患儿120例,随机分为观察组和对照组各60例,两组患儿均给予抗感染、止咳、雾化吸入等常规治疗,观察比较两组疗效。结果观察组治愈48例,有效8例,总有效率93.3%;对照组治愈30例,有效20例,总有效率83.34%,两组治愈率有统计学意义(P<0.05)。结论氨溴特罗佐治小儿喘息性疾病疗效确切,安全有效。
Objective To observe the clinical efficacy of ambroxol on children with wheezing diseases. Methods A total of 120 inpatients with diagnostic criteria from December 2011 to December 2012 were randomly divided into observation group (60 cases) and control group (60 cases). Both groups were given conventional therapy such as anti-infective, cough and inhalation , Observe and compare the curative effect of two groups. Results In the observation group, 48 cases were cured, 8 cases were effective and the total effective rate was 93.3%. In the control group, 30 cases were cured and 20 cases were effective. The total effective rate was 83.34%. The cure rates of the two groups were statistically significant (P <0.05). Conclusion Abruzone treatment of asthmatic children with curative effect is exact, safe and effective.